How Adaptive Biotechnologies and Microsoft are working to ‘decode’ our immune response to COVID-19
Microsoft and its Seattle-based neighbor Adaptive Biotechnologies have been in partnership since 2018 on immuno-sequencing advancements. Now, they’re pivoting their work to collaborate on COVID-19 vaccine development.